Literature DB >> 11078301

Stenting the stent: initial results and long-term clinical and angiographic outcome of coronary stenting for patients with in-stent restenosis.

F Alfonso1, A Cequier, J Zueco, C Morís, C P Suárez, T Colman, E Esplugas, M J Pérez-Vizcayno, C Fernández, C Macaya.   

Abstract

Stent restenosis constitutes a therapeutic challenge affecting an increasing number of patients. Conventional angioplasty and debulking techniques are currently used in these patients. However, the potential role of a second stent implantation in this setting (stenting the stent) remains unknown. Therefore, 65 consecutive patients (12 women, aged 62 +/- 11 years) undergoing stent implantation (42 elective and 23 unplanned) for the treatment of in-stent restenosis (diffuse [> 10 mm] in 39 [60%]) were studied. Angiographic success was obtained in all patients. Three patients developed hospital complications: 1 died from refractory heart failure and 2 suffered non-Q-wave myocardial infarctions. During follow-up (mean 17 +/- 11 months) 1 patient died (noncardiac cause) and only 9 (14%) required target vessel revascularization. Kaplan-Meier event-free survival (freedom from death, myocardial infarction, and target vessel revascularization) at 1 year was 84%. Using Cox analysis, patients with unstable symptoms, a short time to stent restenosis, nonelective stenting, and B2-C lesions tended to have poorer prognosis. After adjustment, nonelective stenting was associated (adjusted RR 2.9, 95% confidence interval [CI] 0.82 to 10.3, p = 0.09) with an adverse clinical outcome. On quantitative angiography (core lab) restenosis was found in 13 of 43 patients (30%) (75% of those eligible). Logistic regression analysis identify restenosis length (adjusted RR 1.43, 95% CI 1.04 to 2.14, p = 0.04), and time to restenosis (adjusted RR 0.67, 95% CI 0.47 to 0.94, p = 0.01) as the only independent predictors of recurrent restenosis. Thus, repeat coronary stenting is a safe and efficacious strategy for the treatment of patients with in-stent restenosis. Both elective and nonelective stenting provide excellent initial results. The long-term clinical and angiographic outcome of these patients is also favorable.

Entities:  

Mesh:

Year:  2000        PMID: 11078301     DOI: 10.1016/s0002-9149(99)00741-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

Review 1.  New recipes for in-stent restenosis: cut, grate, roast, or sandwich the neointima?

Authors:  C Di Mario; F Marsico; M Adamian; E Karvouni; R Albiero; A Colombo
Journal:  Heart       Date:  2000-11       Impact factor: 5.994

2.  Outcomes of second revascularization procedures after stent implantation.

Authors:  Richard P Konstance; Eric L Eisenstein; Kevin J Anstrom; Linda K Shaw; Robert M Califf; Robert A Harrington; David B Matchar; Kevin A Schulman; David F Kong
Journal:  J Med Syst       Date:  2008-04       Impact factor: 4.460

3.  Routine sirolimus eluting stent implantation for unselected in-stent restenosis: insights from the rapamycin eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry.

Authors:  F Saia; P A Lemos; C A Arampatzis; A Hoye; M Degertekin; K Tanabe; G Sianos; P C Smits; W J van der Giessen; P J de Feyter; R T van Domburg; P W Serruys
Journal:  Heart       Date:  2004-10       Impact factor: 5.994

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.